Intuitive Surgical's strong revenue growth and new product rollouts drive share price surge, but investors should be cautious of extreme valuation. Read my ISRG review.

We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...

We present the investment thesis on Perrigo Company plc- a consumer health company which, we believe, is close to an ...

Merus is a buy with Bizengri approval for NRG1+ cancers, Petosemtamab's potential, and partnership with BHVN for oncology ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...